FindMyKOL
Clinical trialNCT03487549CompletedPhase 2Interventional

Cantharidin and Occlusion in Verruca Epithelium

SponsorVerrica Pharmaceuticals Inc.Enrollment56Common WartDNA Virus InfectionsPapillomavirus InfectionsSkin DiseasesSkin Diseases, InfectiousSkin Diseases, Viral+6 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase 2, open label study (Study number VP-102-105; referred to as COVE-1 \[Cantharidin and Occlusion in Verruca Epithelium\]) to evaluate the efficacy, safety and tolerability of VP-102 treatment in subjects with common warts. This study has two Cohorts.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cohort 2: Applied Research Center of Arkansas

    Little Rock, Arkansas, United States

  • Cohort 2: Solutions Through Advanced Research

    Jacksonville, Florida, United States

  • Cohort 2: the Indiana Clinical Trials Center

    Plainfield, Indiana, United States

  • Cohort 2: Clarkston Skin Research

    Clarkston, Michigan, United States

  • Cohort 1-Wake Research Associates

    Raleigh, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Mar 2018
Primary completion
16 May 2019
Completion
15 Jul 2019
Last update posted
27 Nov 2024
Registered enrollment
56
Registry id
NCT03487549
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.